Eurofins BioPharma Services Newsletter 23 - February 2019
ARTICLES:
- Shedding light on phenotypic drug discovery to advance oncology efforts
- Improving cancer treatment with molecular diagnostics
- "One-stop" solution for biocidal products authorisation
- CRISPR/Cas - the system that revolutionises gene editing
- Self Emulsifying Drug Delivery Systems
- Eurofins Lancaster Labs’ newly opened building expansion
Download the PDF version of pharma newsletter N°23
